Quality-adjusted life-years. Ethical implications for physicians and policymakers

J. La Puma and E. F. Lawlor
Center for Clinical Ethics, Lutheran General Hospital, Park Ridge, IL 60068.

Quality-adjusted life-years have been used in economic analyses as a measure of health outcomes, one that reflects both lives saved and patients' valuations of quality of life in alternative health states. The concept of "cost per quality-adjusted life year" as a guideline for resource allocation is founded on six ethical assumptions: quality of life can be accurately measured and used, utilitarianism is acceptable, equity and efficiency are compatible, projections of community preferences can substitute for individual preferences, the old have less "capacity to benefit" than the young, and physicians will not use quality-adjusted life-years as clinical maxims. Quality-adjusted life-years signal two shifts in the locus of control and the nature of the clinical encounter: first, formal expressions of community preferences and societal usefulness would counterbalance patient autonomy, and second, formal tools of resource allocation and applied decision analysis would counterbalance the use of clinical judgment. These shifts reflect and reinforce a new financial ethos in medical decision making. Presently using quality-adjusted life-years for health policy decisions is problematic and speculative; using quality-adjusted life-years at the bedside is dangerous.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids
van Staa et al.
Rheumatology (Oxford) 2007;46:460-466.
ABSTRACT | FULL TEXT  

Cancer Care, Money, and the Value of Life: Whose Justice? Which Rationality?
Sulmasy
JCO 2007;25:217-222.
ABSTRACT | FULL TEXT  

Economic Evaluationin Orthopaedics
Bozic et al.
JBJS 2003;85:129-142.
FULL TEXT  

Initiating End-of-Life Discussions With Seriously Ill Patients: Addressing the "Elephant in the Room"
Quill
JAMA 2000;284:2502-2507.
ABSTRACT | FULL TEXT  

Quality of Life: Erosions and Opportunities Under Managed Care
Morreim
J Law Med Ethics 2000;28:144-158.
 

Health Values of Hospitalized Patients 80 Years or Older
Tsevat et al.
JAMA 1998;279:371-375.
ABSTRACT | FULL TEXT  

Competing Practice Guidelines: Using Cost-Effectiveness Analysis To Make Optimal Decisions
Granata and Hillman
ANN INTERN MED 1998;128:56-63.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of 6 and 12 Months of Interferon-{alpha} Therapy for Chronic Hepatitis C
Kim et al.
ANN INTERN MED 1997;127:866-874.
ABSTRACT | FULL TEXT  

Patient-assessed Health Outcomes in Chronic Lung Disease . What are They, How Do They Help Us, and Where Do We Go From Here?
CURTIS et al.
Am. J. Respir. Crit. Care Med. 1997;156:1032-1039.
FULL TEXT  

Health Values of the Seriously Ill
Tsevat et al.
ANN INTERN MED 1995;122:514-520.
ABSTRACT | FULL TEXT  

Anticipated Changes in the Doctor-Patient Relationship in the Managed Care and Managed Competition of the Health Security Act of 1993
Puma
Arch Fam Med 1994;3:665-671.
ABSTRACT